You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced/metastatic NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Guanzhou, China
    SunYat-senU
May 5, 2023

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

A Multicountry, Multicentre, Non-interventional, Retrospective

Recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Kuwait, Kuwait
      Kuwait Cancer Control Center
    Sep 13, 2023

    NSCLC, NSCLC, PD-1 Trial in Beijing (F520, Pemetrexed, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Feb 22, 2023

    NSCLC Trial in China (BBP-398, osimertinib)

    Recruiting
    • NSCLC
    • Beijing, Beijing, China
    • +4 more
    Sep 4, 2023

    Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 6, 2022

    Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Aug 25, 2023

    NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

    Suspended
    • NSCLC
    • Winter Haven, Florida
      Bond Clinic, P.A.
    Jan 27, 2023

    Response Rate in Patients With Advanced NSCLC on ICI

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Diabetes Mellitus
    • Pembrolizumab
    • Assiut, Egypt
      Assiut university
    Oct 20, 2023

    Lung Cancer Trial (Savolitinib, Durvalumab)

    Recruiting
    • Lung Cancer
    • Beijing, China
    • +2 more
    Jan 11, 2023

    Locally Advanced or Metastatic NSCLC Trial in Ohio City (PBF-1129)

    Active, not recruiting
    • Locally Advanced or Metastatic NSCLC
    • Ohio City, Ohio
      Division of medical Oncology A450B Starling Loving Hall
    Jan 24, 2023

    Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

    Not yet recruiting
    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    • (no location specified)
    May 8, 2023

    NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Stereotactic body radiation therapy (SBRT)
    • Temporary Stopping
    • Stockholm, Solna, Sweden
      Karolinska University Hospital
    Nov 9, 2023

    Advanced or Metastatic NSCLC Trial in Guangzhou (HS-10375)

    Recruiting
    • Advanced or Metastatic NSCLC
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 27, 2022

    NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Mar 17, 2023

    NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Jun 1, 2023

    NSCLC (NSCLC) Trial in New York (Pembrolizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • New York, New York
      Mount Sinai Hospital
    Jan 23, 2023

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • NSCLC
    • (no location specified)
    Jul 17, 2022

    Non-squamous NSCLC Trial (biological, drug, dietary supplement)

    Not yet recruiting
    • Non-squamous NSCLC
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Feb 20, 2023

    KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

    Recruiting
    • KRAS P.G12C
    • Non Small Cell Lung Cancer
    • Sotorasib 120Mg Tab
    • Lyon, France
    • +3 more
    Dec 16, 2022

    Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

    Recruiting
    • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 21, 2023

    Lazertinib as the 2nd-Line Treatment in EGFR Mutation+ NSCLC

    Completed
    • Non-small Cell Lung Cancer
    • (no location specified)
    May 8, 2023